We are live on ! Find out more
BIP

Brandes Investment Partners Portfolio holdings

AUM $14.1B
1-Year Est. Return 25.52%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+25.52%
3 Year Est. Return
+82.74%
5 Year Est. Return
+120.97%
10 Year Est. Return
+869.55%
AUM
$4.96B
AUM Growth
+$253M
Cap. Flow
-$28.4M
Cap. Flow %
-0.57%
Top 10 Hldgs %
28.77%
Holding
159
New
5
Increased
78
Reduced
63
Closed
8

Top Buys

Rank Stock Value
1
WRB icon
W.R. Berkley
WRB
+$19.2M
2
CVS icon
CVS Health
CVS
+$16.7M
3
PFE icon
Pfizer
PFE
+$16.6M
4
SSNC icon
SS&C Technologies
SSNC
+$15.1M
5
MHK icon
Mohawk Industries
MHK
+$12.4M

Top Sells

Rank Stock Value
1
CX icon
Cemex
CX
+$55.4M
2
HCA icon
HCA Healthcare
HCA
+$31.7M
3
EMBJ
Embraer S.A. ADS
EMBJ
+$13.6M
4
FISV
Fiserv Inc
FISV
+$12.5M
5
CAH icon
Cardinal Health
CAH
+$11.3M

Sector Composition

Rank Sector Weight
1 Healthcare 23.13%
2 Financials 21.71%
3 Industrials 15.52%
4 Technology 13.35%
5 Energy 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWLI
51
DELISTED
National Western Life Group, Inc. Class A
NWLI
$30.3M 0.61%
73,005
-34,023
-32% -$10.8M
ELAN icon
52
Elanco Animal Health
ELAN
$11.4B
$29.3M 0.59%
2,912,795
+851,823
+41% +$7.91M
JNJ icon
53
Johnson & Johnson
JNJ
$626B
$28.4M 0.57%
171,543
+8,391
+5% +$1.35M
SAP icon
54
SAP
SAP
$242B
$28.2M 0.57%
206,286
-23,024
-10% -$3.04M
TAK icon
55
Takeda Pharmaceutical
TAK
$55.8B
$27.7M 0.56%
1,765,319
-52,653
-3% -$863K
BRK.B icon
56
Berkshire Hathaway Class B
BRK.B
$1.11T
$27.1M 0.55%
79,510
+4,287
+6% +$1.4M
INGR icon
57
Ingredion
INGR
$6.6B
$27.1M 0.55%
255,892
-35,538
-12% -$3.78M
FOX icon
58
Fox Class B
FOX
$23.2B
$25.3M 0.51%
794,248
+36,637
+5% +$1.11M
AZO icon
59
AutoZone
AZO
$49.7B
$25M 0.5%
10,019
+383
+4% +$977K
WKC icon
60
World Kinect Corp
WKC
$1.88B
$24.8M 0.5%
1,196,842
+76,838
+7% +$1.83M
WRB icon
61
W.R. Berkley
WRB
$26B
$24.4M 0.49%
614,058
+488,784
+390% +$19.2M
BABA icon
62
Alibaba
BABA
$306B
$24.4M 0.49%
292,430
-11,143
-4% -$975K
EPC icon
63
Edgewell Personal Care
EPC
$1.32B
$23.7M 0.48%
573,237
-135,987
-19% -$5.81M
GSK icon
64
GSK
GSK
$102B
$23.2M 0.47%
650,492
+8,649
+1% +$310K
TTE icon
65
TotalEnergies
TTE
$195B
$22.5M 0.45%
390,653
-1,228
-0.3% -$74.3K
AVDL
66
DELISTED
Avadel Pharmaceuticals
AVDL
$21.2M 0.43%
1,289,195
-155,440
-11% -$2.02M
WPP icon
67
WPP
WPP
$5.83B
$19.7M 0.4%
376,861
+27,108
+8% +$1.52M
PKE icon
68
Park Aerospace
PKE
$815M
$19.5M 0.39%
1,412,494
+60,086
+4% +$795K
NVS icon
69
Novartis
NVS
$294B
$18.7M 0.38%
185,226
-4,425
-2% -$443K
PAHC icon
70
Phibro Animal Health
PAHC
$1.38B
$18.5M 0.37%
1,352,603
+72,304
+6% +$1.04M
PHG icon
71
Philips
PHG
$26.4B
$18.2M 0.37%
936,271
-47,884
-5% -$838K
E icon
72
ENI
E
$80.3B
$18.2M 0.37%
630,669
-25,427
-4% -$737K
HMC icon
73
Honda
HMC
$41.1B
$18.1M 0.36%
595,942
-87,265
-13% -$2.46M
TARO
74
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$17.9M 0.36%
472,899
+10,543
+2% +$331K
PBR.A icon
75
Petrobras Class A
PBR.A
$103B
$17.7M 0.36%
1,432,334
+3,089
+0.2% +$33.7K
1 2
3
4 5

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Brandes Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Brandes Investment Partners held 159 positions worth $4.96B, up 5.4% from $4.71B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Brandes Investment Partners's Q2 2023 filing shows 5 new, 78 increased, 63 reduced and 8 closed positions. Its largest new stake was SS&C Technologies: 265,050 shares worth $16.1M. The largest sale was Cemex, an estimated $55.4M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Brandes Investment Partners's largest Q2 2023 buy was SS&C Technologies: 265,050 shares worth $16.1M.
  • Brandes Investment Partners added most to W.R. Berkley in Q2 2023, an estimated $19.2M increase.
  • Brandes Investment Partners's biggest Q2 2023 reduction was Cemex, cutting an estimated $55.4M.
  • Brandes Investment Partners fully exited Oracle in Q2 2023, selling an estimated $9.31M.
  • Brandes Investment Partners's ten largest holdings make up 29% of its $4.96B portfolio in Q2 2023.
  • Brandes Investment Partners opened 5 new positions and closed 8 in Q2 2023.
  • Brandes Investment Partners's portfolio value rose 5.4% quarter-over-quarter to $4.96B.

Based on Brandes Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.